David Munn

Co-Director

David Munn

Co-Director

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Pediatrics: Hematology/Oncology

Medical College of Georgia
Department of Pathology

Medical College of Georgia
Department of Medicine

Medical College of Georgia
Department of Biochemistry and Molecular Biology

Medical College of Georgia
Department of Cellular Biology and Anatomy

Administration
Department of The Graduate School

Bio

Dr. Munn is a physician-scientist (pediatric oncology) with an interest in immunotherapy of pediatric cancer.

Education

  • MD, Medicine Medical College of Georgia, 1984

  • BA, Philosophy Mercer University, 1978

Certifications

  • PHY No PrivilegesJ Adams 12.30.15, 1990

Teaching Interests

Dr. Munn teaches medical school classes in the histology of blood and lymphoid tissues. He participates in the professional education (conferences, teaching and supervision) of medical students, graduate students, post-doctoral fellows and junior faculty in his area of tumor immunology research.

Scholarship

Selected Recent Publications

  • Role of the Tumor Microenvironment, 2021
    Book, Chapter in Textbook-New
  • Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity, 2021
    Journal Article, Professional Journal
  • Phase II Trail of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma, 2021
    Journal Article, Professional Journal
  • Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T-cells, 2020
    Journal Article, Professional Journal
  • Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subject with Glioblastoma, 2020
    Journal Article, Professional Journal

Research Interests

Dr. Munn's research focuses on activating the immune system of children with cancer, so that they can mount an immune attack against the tumor. He has an active research laboratory in pre-clinical drug discovery, as well as implementing cutting-edge techniques for monitoring the immune response of children on immunotherapy clinical trials. He participates as a laboratory co-investigator on multiple clinical trials of new drugs and treatments that were invented in his laboratory.

Department Service

  • GCC Internal Promotion and Tenure Advisory Committee 2020

    Role: Committee Chair
  • GCC PRMC Committee (Protocol Review and Monitoring Committee 2020

    Role: Committee Chair

University Service

  • GCC Director Search Committee 2019

    Role: Administrative Assignment, Other

Professional Service

  • - 2015

    Role: Reviewer